Novo Nordisk
NVO
#78
Rank
HK$1.616 T
Marketcap
HK$363.84
Share price
-2.28%
Change (1 day)
-57.22%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Total debt

Total debt on the balance sheet as of September 2025 : HK$123.81 Billion

According to Novo Nordisk's latest financial reports the company's total debt is HK$123.81 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Novo Nordisk - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31HK$111.34 B256.45%
2023-12-31HK$31.23 B7.67%
2022-12-31HK$29.01 B-8.29%
2021-12-31HK$31.63 B138.36%
2020-12-31HK$13.27 B153.5%
2019-12-31HK$5.23 B747.2%
2018-12-31HK$0.61 B-71.04%
2017-12-31HK$2.13 B748.6%
2016-12-31HK$0.25 B-79.37%
2015-12-31HK$1.21 B33.62%
2014-12-31HK$0.91 B195.51%
2013-12-31HK$0.30 B-55.08%
2012-12-31HK$0.68 B-40.46%
2011-12-31HK$1.15 B-62.63%
2010-12-31HK$3.08 B48.99%
2009-12-31HK$2.07 B-38.46%
2008-12-31HK$3.36 B61.69%
2007-12-31HK$2.08 B-0.23%
2006-12-31HK$2.08 B-36.8%
2005-12-31HK$3.30 B36.86%
2004-12-31HK$2.41 B6.31%
2003-12-31HK$2.27 B35.4%
2002-12-31HK$1.67 B-17.78%
2001-12-31HK$2.04 B-4.39%
2000-12-31HK$2.13 B-11.58%
1999-12-31HK$2.41 B-27.15%
1998-12-31HK$3.31 B-11.15%
1997-12-31HK$3.72 B35.32%
1996-12-31HK$2.75 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
HK$473.35 B 282.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$330.67 B 167.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$397.06 B 220.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$198.61 B 60.42%๐Ÿ‡ซ๐Ÿ‡ท France